US · RZC · INSURANCE - DIVERSIFIED
Reinsurance Group of America, Incorporated (RZC) intrinsic value and stock valuation
$25.19as of 2026-11-21 · Mkt cap 15.54B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Reinsurance Group of America, Incorporated DCF and intrinsic value
InvestorsCraft values RZC with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from RZC’s statements →
Reinsurance Group of America, Incorporated Graham Number
Graham Number: $287.25d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Jackson Financial Inc. (JXN) $127.12
- Acadian Asset Management (AAMI) $80.26
- Federal Agricultural Mortgage (AGM) $162.11
- The Bank of N.T. Butterfield & Son Limited (NTB) $53.63
- First Commonwealth Financial Corporation (FCF) $20.03
- Bladex, Inc. (BLX) $46.90
- FinVolution Group (FINV) $2.48
- Maiden Holdings North America, Ltd. (MHNC) $9.10
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $22.8B | $22B | $18.4B | $15.9B | $16.1B |
| Operating income | $1.54B | $980M | $1.16B | $718M | $1.39B |
| Net income | $1.18B | $717M | $902M | $517M | $1.17B |
| EPSd | $17.7M | $10.7M | $13.4M | $7.64M | $17.1M |
| Operating cash flow | $4.09B | $9.37B | $4.04B | $1.34B | $4.18B |
| Capital expenditure | $0.00 | $0.00 | $0.00 | -$-25M | -$-19M |
| Free cash flow | $4.09B | $9.37B | $4.04B | $1.32B | $4.16B |
| Total assets | $156.6B | $118.7B | $97.6B | $84.9B | $92.2B |
| Total debt | $5.71B | $5.04B | $4.43B | $3.96B | $3.85B |
| Net debt | $1.54B | $1.72B | $1.46B | $1.03B | $899M |
| Total equity | $13.6B | $10.9B | $9.17B | $7.17B | $13B |
| Cash and short-term investments | $4.17B | $3.33B | $2.97B | $2.93B | $2.95B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $22.8B | $22B | $18.4B | $15.9B | $16.1B |
| Cost of revenue | $17B | $19.6B | $16.1B | $14.3B | $14.2B |
| Gross profit | $5.79B | $2.49B | $2.33B | $1.57B | $1.85B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other expenses | $4.25B | $1.51B | $1.17B | $853M | $469M |
| Operating expenses | $4.25B | $1.51B | $1.17B | $853M | $469M |
| Cost and expenses | $21.3B | $21.1B | $17.2B | $15.2B | $14.7B |
| Interest income | $320M | $341M | $317M | $253M | $351M |
| Interest expense | $366M | $304M | $257M | $191M | $139M |
| Depreciation and amortization | $43M | $46M | $41M | $38M | $43M |
| Ebitda | $1.95B | $1.33B | $1.46B | $947M | $1.57B |
| Operating income | $1.54B | $980M | $1.16B | $718M | $1.39B |
| Total other income/expenses, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income before tax | $1.54B | $980M | $1.16B | $718M | $1.39B |
| Income tax expense | $351M | $256M | $251M | $197M | $215M |
| Net income | $1.18B | $717M | $902M | $517M | $1.17B |
| Weighted average shares outstanding | $66.1M | $65.8M | $67.1M | $67.7M | $67.8M |
| Weighted average diluted shares outstanding | $66.7M | $66.9M | $67.1M | $67.7M | $68.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.17B | $3.33B | $2.97B | $2.93B | $2.95B |
| Net receivables | $4.48B | $3.9B | $3.53B | $3.01B | $2.89B |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $8.64B | $7.22B | $6.5B | $5.94B | $5.84B |
| Property, plant and equipment, net | $480M | $450M | $416M | $408M | $284M |
| Goodwill and intangible assets | $6M | $8M | $11M | $14M | $12M |
| Long-term investments | $130.5B | $98B | $78.9B | $70.5B | $78.5B |
| Total non-current assets | $147.9B | $111.5B | $91.1B | $79B | $86.3B |
| Total assets | $156.6B | $118.7B | $97.6B | $84.9B | $92.2B |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Short-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term debt | $5.71B | $5.04B | $4.43B | $3.96B | $3.85B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $143B | $107.8B | $88.5B | $77.7B | $79.2B |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $143B | $107.8B | $88.5B | $77.7B | $79.2B |
| Common stock | $1M | $1M | $1M | $1M | $1M |
| Retained earnings | $10.2B | $9.26B | $8.81B | $8.17B | $8.56B |
| Accumulated other comprehensive income (loss) | $2.68B | $849M | -$-369M | -$-1.87B | $3.64B |
| Total equity | $13.6B | $10.9B | $9.17B | $7.17B | $13B |
| Total investments | $130.5B | $98B | $78.9B | $70.5B | $78.5B |
| Total debt | $5.71B | $5.04B | $4.43B | $3.96B | $3.85B |
| Net debt | $1.54B | $1.72B | $1.46B | $1.03B | $899M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $1.18B | $717M | $902M | $517M | $617M |
| Depreciation and amortization | $43M | $46M | $41M | $38M | -$-11M |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $3.17B | $8.26B | $3.14B | $442M | $4.31B |
| Accounts receivable | -$-355M | -$-166M | -$-746M | -$-188M | $14M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $4.09B | $9.37B | $4.04B | $1.34B | $4.18B |
| Investments in property, plant and equipment | $0.00 | $0.00 | $0.00 | -$-25M | -$-19M |
| Acquisitions, net | -$-527M | -$-320M | -$-77M | $17M | -$-287M |
| Net cash used for investing activities | -$-12.09B | -$-12.55B | -$-4.07B | -$-5.69B | -$-4.63B |
| Common stock issued | $4M | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-174M | -$-27M | -$-227M | -$-81M | -$-99M |
| Dividends paid | -$-240M | -$-229M | -$-219M | -$-205M | -$-194M |
| Net cash used for financing activities | $8.8B | $3.66B | $78M | $4.44B | $20M |
| Net change in cash | $842M | $356M | $43M | -$-21M | -$-460M |
| Cash at end of period | $4.17B | $3.33B | $2.97B | $2.93B | $2.95B |
| Operating cash flow | $4.09B | $9.37B | $4.04B | $1.34B | $4.18B |
| Capital expenditure | $0.00 | $0.00 | $0.00 | -$-25M | -$-19M |
| Free cash flow | $4.09B | $9.37B | $4.04B | $1.32B | $4.16B |
Line items
Line items
Line items
About Reinsurance Group of America, Incorporated
Reinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance. In Canada, the company's focus is on individual life reinsurance, supplemented by a lesser extent of creditor, group life and health, critical illness, and disability reinsurance, generally through yearly renewable term and coinsurance contracts. The EMEA segment provides individual and group life and health products, including critical illness coverage—which offers a benefit upon the diagnosis of a specified illness—and underwritten annuities, typically facilitated via yearly renewable term and coinsurance agreements. The Asia Pacific segment covers individual and group life and health reinsurance, critical illness coverage, disability, and superannuation, predominantly structured with yearly renewable term and coinsurance agreements. Finally, the Corporate and Other segment encompasses investment income from unallocated assets, investment-related gains and losses, and service fee revenues. Founded in 1973, the company's corporate headquarters are situated in Chesterfield, Missouri.
- CEO
- Tony Cheng
- Employees
- 3.9K
- Beta
- 0.18
Explore
Frequently asked questions
What is the intrinsic value of Reinsurance Group of America, Incorporated (RZC)?
InvestorsCraft does not currently publish an intrinsic value for RZC. How the IC value is calculated.
Is RZC undervalued?
InvestorsCraft does not publish an undervaluation signal for RZC at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.